Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study
This human factors study demonstrated that the zilucoplan PFS is safe and effective for intended users, including patients with gMG and their caregivers.
Authors
- Barbara Domańska (ORCID: https://orcid.org/0000-0002-7424-1726)
- Maria Isabel Leite (ORCID: https://orcid.org/0000-0002-4277-9855)
- Katherine Ruzhansky (ORCID: https://orcid.org/0000-0001-7234-3254)
- Mohammad Ashraghi (ORCID: https://orcid.org/0000-0002-1076-6822)
- Babak Boroojerdi
- Alessandra Franchini
Institutions
- Medical University of South Carolina (US)
- UCB Pharma (United Kingdom) (GB)
- Science Oxford (GB)
- UCB Pharma (Germany) (DE)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- Expert Review of Medical Devices
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1080/17434440.2024.2403700
- Citations
- 2
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.74